v3.22.0.1
Stock-Based Compensation - Summary of Stock Appreciation Rights Activity (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Vested and exercisable, ending balance (in shares) 232,500
Stock appreciation rights (“SARs”)  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Beginning balance (in shares) 679,500
Exercised (in shares) (205,832)
Forfeited/Canceled (in shares) (6,000)
Ending balance (in shares) 467,668
Vested and exercisable, ending balance (in shares) 89,968
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]  
Beginning balance (in usd per share) | $ / shares $ 51.99
Exercised (in usd per share) | $ / shares 48.41
Forfeited/Canceled (in usd per share) | $ / shares 53.01
Ending balance (in usd per share) | $ / shares 53.55
Vested and exercisable, ending balance (in usd per share) | $ / shares $ 50.85
Outstanding, weighted average contractual term, ending balance (in years) 7 years 1 month 6 days
Vested and exercisable, weighted average contractual term, ending balance (in years) 6 years 6 months
Outstanding, aggregate intrinsic value, ending balance | $ $ 41,880
Vested and exercisable, aggregate intrinsic value, ending balance | $ $ 8,300
Granted (in shares) 0